Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. (2016)

First Author: Strehl C
Attributed to:  Advancing therapeutics by exploiting single cell functional analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2015-208916

PubMed Identifier: 26933146

Publication URI: http://europepmc.org/abstract/MED/26933146

Type: Journal Article/Review

Volume: 75

Parent Publication: Annals of the rheumatic diseases

Issue: 6

ISSN: 0003-4967